Thyrocare Technologies Limited (NSE:THYROCARE)
India · Delayed Price · Currency is INR 584.00
+18.45 (3.26%)
Aug 24, 2026, 3:30 PM IST
Thyrocare Technologies Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 92,984 | 55,668 | 36,046 | 31,359 | 22,744 | 40,934 | |
Market Cap Growth | 38.99% | 54.44% | 14.95% | 37.88% | -44.44% | -14.26% |
Enterprise Value | 91,598 | 53,990 | 34,861 | 30,849 | 21,746 | 39,986 |
Last Close Price | 584.00 | 345.06 | 218.90 | 186.12 | 130.77 | 231.23 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 52.74 | 34.14 | 39.39 | 44.32 | 35.27 | 23.24 |
PS Ratio | 10.61 | 6.72 | 5.24 | 5.48 | 4.32 | 6.95 |
PB Ratio | 15.87 | 9.50 | 6.59 | 5.94 | 4.25 | 7.77 |
P/TBV Ratio | 19.63 | 11.75 | 8.31 | 7.43 | 5.25 | 9.62 |
P/FCF Ratio | 48.34 | 28.94 | 24.62 | 29.57 | 26.55 | 54.16 |
P/OCF Ratio | 43.61 | 26.11 | 20.04 | 18.71 | 17.59 | 36.09 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 10.46 | 6.51 | 5.07 | 5.39 | 4.13 | 6.79 |
EV/EBITDA Ratio | 32.47 | 22.22 | 19.95 | 23.71 | 19.15 | 17.44 |
EV/EBIT Ratio | 40.88 | 26.50 | 25.79 | 33.64 | 26.46 | 19.89 |
EV/FCF Ratio | 47.62 | 28.07 | 23.81 | 29.09 | 25.39 | 52.91 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.05 | 0.08 | 0.04 | 0.04 |
Debt / EBITDA Ratio | 0.18 | 0.19 | 0.13 | 0.31 | 0.19 | 0.09 |
Debt / FCF Ratio | - | 0.26 | 0.17 | 0.40 | 0.27 | 0.27 |
Net Debt / Equity Ratio | -0.24 | -0.24 | -0.24 | -0.20 | -0.22 | -0.22 |
Net Debt / EBITDA Ratio | -0.53 | -0.57 | -0.75 | -0.80 | -1.03 | -0.51 |
Net Debt / FCF Ratio | - | -0.72 | -0.89 | -0.98 | -1.36 | -1.56 |
Asset Turnover | - | 1.15 | 1.03 | 0.90 | 0.85 | 1.02 |
Inventory Turnover | - | 7.34 | 6.44 | 7.18 | 8.80 | 8.15 |
Quick Ratio | - | 2.47 | 1.95 | 2.10 | 2.93 | 3.62 |
Current Ratio | - | 3.39 | 2.77 | 3.08 | 3.54 | 4.18 |
Return on Equity (ROE) | - | 28.74% | 16.89% | 13.08% | 12.12% | 36.93% |
Return on Assets (ROA) | - | 17.69% | 12.64% | 8.98% | 8.28% | 21.78% |
Return on Invested Capital (ROIC) | 37.91% | 36.10% | 20.07% | 15.77% | 14.44% | 42.80% |
Return on Capital Employed (ROCE) | - | 32.00% | 23.70% | 16.60% | 14.80% | 37.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.90% | 2.93% | 2.54% | 2.26% | 2.83% | 4.30% |
FCF Yield | 2.07% | 3.45% | 4.06% | 3.38% | 3.77% | 1.85% |
Dividend Yield | 1.65% | 2.70% | 3.20% | 3.22% | 4.59% | 2.16% |
Payout Ratio | - | 91.04% | 104.15% | 134.64% | 123.04% | 45.03% |
Buyback Yield / Dilution | -0.40% | -0.05% | -0.27% | -0.06% | -0.05% | -0.06% |
Total Shareholder Return | 1.25% | 2.65% | 2.93% | 3.16% | 4.54% | 2.11% |